Organization
Academic Specialist Center, Center for Rheumatology, Stockholm, Sweden
2 abstracts
Abstract
AMLEXANOX INHIBITS PRODUCTION OF TYPE I INTERFERON AND SUPPRESSES B CELL DIFFERENTIATION AND IMMUNOGLOBULIN PRODUCTION IN VITRO: A POTENTIAL NOVEL THERAPEUTIC OPTION FOR SLEOrg: Karolinska Institutet, Department of Medicine, Stockholm, Sweden, Academic Specialist Center, Center for Rheumatology, Stockholm, Sweden, Erasmus MC, University Medical Center Rotterdam, Department of Immunology, Rotterdam, Netherlands, Sophia Children’s Hospital, Erasmus MC, University Medical Center Rotterdam, Department of Paediatric Rheumatology, Rotterdam, Netherlands,
Abstract
ANALYSES OF PLASMA METABOLIC PROTEINS REVEAL BIOMARKERS PREDICTIVE OF SUBSEQUENT DEVELOPMENT OF GIANT CELL ARTERITIS; A PROSPECTIVE STUDYOrg: Lund University, Academic Specialist Center, Center for Rheumatology, Stockholm, Sweden, University of Gothenburg, Skåne University Hospital, Lund University, University of Cambridge,